OB/GYN Docs in U.S. Want COVID-19 Vaccines Tested on Pregnant Women

OB/GYN Docs in U.S. Want COVID-19 Vaccines Tested on Pregnant Women

A U.S. Centers for Disease Control and Prevention (CDC) report1 on pregnancy and SARS-CoV-2 infection released on June 26 suggested that pregnant women may be at increased risk for COVID-19 complications. The report was followed by a statement issued by the American College of Obstetricians and Gynecologists (ACOG)2 urging that pregnant and lactating women be […]

Will Newborns Be Separated from Parents for COVID-19 Testing?

Will Newborns Be Separated from Parents for COVID-19 Testing?

Opinion | The Bill & Melinda Gates Foundation is the biggest funder of vaccines in the entire world and, according to Gates, its COVID-19 vaccination effort “dwarfs anything we’ve ever worked on before.”1 Indeed, Gates push for mandatory COVID-19 vaccination—and investment in those vaccines—is historically unprecedented. In an Apr. 30, 2020 GatesNotes post,2,3 Gates even […]

Virginia Legislature Gives CDC, Board of Health Power to Mandate Vaccines for School Children

Virginia Legislature Gives CDC, Board of Health Power to Mandate Vaccines for School Children

In the 2020 Legislative session, the Virginia Legislature passed H.B.1090, a bill that amended a law requiring children attending public and private schools in the state to receive vaccines (§ 32.1-46. Immunization of patients against certain diseases).1 Virginia Delegate Patrick Hope (D-Arlington) was the lead sponsor of H.B. 1090 introduced on Jan. 8, 2020, which […]

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually

In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]

Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine Trial

Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine Trial

Of the 45 volunteers in biotechnology company Moderna, Inc.’s Phase 1 human clinical trial on its experimental mRNA-1273 vaccine for COVID-19, only the names of the first two participants have been widely publicized—Jennifer Haller of Seattle, Washington and Neal Browning of Bothell, Washington. The clinical trial began on Mar. 16, 2020 at Kaiser Permanente Washington […]

Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.

Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant

Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

Pfizer/BioNTech Target Fall 2020 for COVID-19 Vaccine Availability

In recent weeks Inovio Pharmaceuticals of Pennsylvania and representatives of the German biotechnology firm CureVac AG and the University of Oxford in the United Kingdom have announced that their experimental COVID-19 vaccines will be ready for use by September 2020. On Apr. 29, 2020, Pfizer, Inc. of New York stated in a news release that […]

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

Oxford Begins COVID-19 Vaccine Trials to Meet September Deadline

On Mar. 17, 2020, European Commission (EC) president Ursula von der Leyen said she was hopeful a vaccine for COVID-19 could be available this September. Her view was based on conversations she had had with managers of German biotechnology firm CureVac AG which has developed an experimental messenger RNA (mRNA) vaccine that it plans to […]